Sort
48,018 grants matching “immunotherapy”
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
$2,801,829Judith S. Currier · University Of California Los Angeles · UM1 · FY2024 · AI
Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment
$2,800,993David E Fisher · Massachusetts General Hospital · P01 · FY2024 · CA
SPORE in Skin Cancer
$2,800,906Brigham And Women'S Hospital · P50 · FY2002 · CA
ETIB Clinical Research Core
$2,789,851Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2018 · CA
THERAPY OF CML
$2,789,679University Of Texas Md Anderson Can Ctr · P01 · FY2002 · CA
Cytokine signaling, immunoregulation and autoimmune disease
$2,782,678John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2021 · AR
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
$2,782,255Carl H. June · University Of Pennsylvania · P01 · FY2023 · CA
Vaccine Induced Immunity in the Young and Aged
$2,782,096Rafi Ahmed · Emory University · U19 · FY2021 · AI
Pediatric Brain Tumor Consortium (PBTC)
$2,781,436Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2019 · CA
Development of anti-LPS therapeutic antibodies for the treatment of Pseudomonas aeruginosa infections
$2,779,955Mariette Barbier · West Virginia University · R01 · FY2025 · AI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,779,530Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Synergies among inhibitory receptors in tolerance and disease
$2,775,439Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2025 · AI
Statistics Core for SWOG SDMC
$2,771,034Michael Leo Leblanc · Fred Hutchinson Cancer Center · U10 · FY2024 · CA
Bone Marrow Transplantation in Human Disease
$2,770,981Johns Hopkins University · P01 · FY2005 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,767,364Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Comprehensive Cancer Center Program at Fox Chase
$2,763,834Richard I Fisher · Research Inst Of Fox Chase Can Ctr · P30 · FY2017 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,760,232Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2019 · CA
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
$2,756,111Carl H. June · University Of Pennsylvania · P01 · FY2019 · CA
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$2,755,137Rachel R. Caspi · National Eye Institute · ZIA · FY2016 · EY
Statistics Core for SWOG SDMC
$2,750,305Michael Leo Leblanc · Fred Hutchinson Cancer Research Center · U10 · FY2020 · CA
Consolidated Basic Cancer Research Program
$2,749,311Dario C. Altieri · Wistar Institute · P30 · FY2019 · CA
The Biology of HIV Infections
$2,748,797Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,747,943Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2018 · CA
The Role of Inflammasome Signaling in Tauopathies
$2,745,818Kiran Bhaskar · University Of New Mexico Health Scis Ctr · RF1 · FY2020 · NS
Bone Marrow Transplantation in Human Disease
$2,743,438Johns Hopkins University · P01 · FY2002 · CA